ETHISPHERE NAMES ELBIT AMERICA AS ONE OF THE 2023 WORLD'S MOST ETHICAL COMPANIES
Recognition honors companies demonstrating business integrity through best-in-class ethics, compliance, and governance practices
Elbit America's Lisa Northup featured as Force Multiplier by Breaking Defense
On Jan. 21, 2023, Elbit America's Lisa Northup was featured in Defense Daily's monthly column, Force Multipliers. Access the...
Elbit America employees take part in Light The Night in Tarrant County
Elbit America team is top corporate fundraiser for the 2022 event in Fort Worth, Texas
By Summer Richie
On Nov. 6, 2022, Elbit...
Elbit America awards 87 scholarships to employee dependents
Elbit America has awarded scholarships to 87 undergraduate college students who are the dependents of current members of its...
Elbit America supports the Leukemia & Lymphoma Society through Ribfest
By Summer Richie and Lauren Price
Save and protect American lives. Those five words hold great meaning within Elbit Systems of...
Embracing core values with Environmental, Social and Governance program
By Summer Richie
Do the right thing. It’s one of Elbit America’s core values and serves as a compass for how the company and...
Elbit Systems of America partners with Texas A&M University on first Texas Manufacturing Renaissance Conference
Roughly 100 participants gathered from across the region to hear how Texas can contribute to national defense and economic...
Elbit America Breaks Ground on New South Carolina Facility
Elbit Systems of America (Elbit America) is establishing a new, 135,000-square-foot facility to be located at Crosspoint at...
Elbit Systems of America is named 2022 World's Most Ethical Company
FORT WORTH, TEXAS – March 15, 2022- Elbit Systems of America (Elbit America), a leader in high-end technologies that support...
Leukemia & Lymphoma Society Makes Major Impact with Financial Assistance for Patients and Research Funding
By Jacob Meyer, Communications Intern
The Elbit America workforce are proud donors and advocates for the Leukemia & Lymphoma...
